US News

We’re on the brink of an epic Lyme disease outbreak

A bumper crop of acorns could be putting the US on the brink of an unprecedented outbreak of Lyme disease, experts warn.

An estimated 300,000 Americans are diagnosed with Lyme disease each year, but the illness is now on track to being the worst in 2017, according to Rick Ostfeld, a disease ecologist at the Cary Institute of Ecosystem Studies in Millbrook, New York.

The acorn surge means mouse populations will climb — giving rise to more disease-carrying ticks.

“We predict the mice population based on the acorns and we predict infected nymph ticks with the mice numbers. Each step has a one-year lag,” Ostfeld told New Scientist magazine.

One mouse alone can carry hundreds of immature ticks, according New Scientist.

The rodents’ blood contains the Lyme-causing bacterium Borrelia burgdorferi, which gets transferred to the tick’s stomach as it feeds. The bacteria can then be passed on to whatever new host — like humans — the tick latches onto.

With no Lyme disease vaccine available — the last one, Lymerix, was yanked off the market in 2002 — little can be done to prevent the illness outside of the standard anti-tick measures, including wearing long pants in the woods and performing thorough self-checks.

Ticks are tiny, as small as a poppy seed, and easy to miss, and not everyone gets the bullseye rash that usually accompanies a Lyme-infected tick bite. The flu-like symptoms that occur after being infected are also easy to misdiagnose.

“That’s when you get late-stage, untreated, supremely problematic Lyme disease,” Ostfeld said.

There’s a new Lyme vaccine, produced by French-based biotech group Valneva, but it’s in early human trials and at least six years away from being publicly released.

Lyme disease diagnoses could soon soar globally, too.

Researchers in Poland discovered the same acorn trends last year.

“Last year we had a lot of oak acorns, so we might expect 2018 will pose a high risk of Lyme,” Jakub Szymkowiak from the Adam Mickiewicz University in Poznan, Poland, told New Scientist.